Nordson’s Q1 Sales Rise 9% to $669M, EBITDA Hits $203M Record
Nordson reported record Q1 sales of $669 million, up 9% year-over-year (7% organic), delivering record EBITDA of $203 million (30% margin) and adjusted EPS of $2.37, up 15%. Free cash flow reached $123 million, while Advanced Technology Solutions sales climbed 23% to $149 million on semiconductor demand.
1. Q1 Financial Highlights
Nordson posted record quarterly sales of $669 million, marking a 9% increase year-over-year (7% organic). Adjusted operating profit rose 10% to $166 million, EBITDA reached a record $203 million at a 30% margin, and adjusted EPS climbed 15% to $2.37. Free cash flow was $123 million with cash conversion above 100%.
2. Segment Performance
Advanced Technology Solutions led growth with sales of $149 million, up 23% year-over-year (21% organic), driven by semiconductor dispense and test systems. Industrial Precision Solutions delivered $327 million in sales, up 9% (3% organic, 6% currency), with EBITDA of $110 million (34% margin). Medical and Fluid Solutions generated $193 million, flat year-over-year but up 3% organically, with EBITDA of $70 million (36% margin).
3. Capital Deployment and Outlook
The company returned $82 million to shareholders through buybacks and $46 million in dividends, ending the quarter with $1.9 billion net debt (2.1x leverage). Management raised full-year guidance to $2.86–$2.98 billion in sales and $11.00–$11.60 in adjusted EPS, citing broad-based demand trends and ongoing margin normalization.